Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company trades wholesale and retail in pharmaceutical products sourced locally. Registered on 1 July 1995.
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 13.4% | 13.6% | 14.6% | 14.4% | 14.1% | 11.0% | 10.3% |
| EBITDA Margin | 5.2% | 5.7% | 5.4% | 5.4% | 3.2% | -3.6% | -5.4% |
| EBITDAR | 164 | 195 | 195 | 201 | 126 | -43 | -83 |
| EBITDAR Margin | 6.5% | 6.7% | 6.4% | 6.4% | 4.4% | -2.0% | -3.6% |
| EBIT Margin | 5.0% | 5.4% | 5.3% | 5.3% | 3.1% | -3.9% | -6.0% |
| Net Profit Margin | 4.6% | 4.9% | 4.9% | 5.0% | 2.6% | -4.1% | -6.4% |
| Operating Expense % of Sales | 8.2% | 8.0% | 9.2% | 9.0% | 10.9% | 14.6% | 15.7% |
| Returns | |||||||
| Return on Assets (ROA) | 20.7% | 23.5% | 21.0% | 20.7% | 9.2% | -12.2% | -24.5% |
| Return on Equity (ROE) | 29.6% | 31.4% | 25.5% | 23.6% | 11.7% | -16.4% | -49.4% |
| ROIC [EBIT / Invested Capital] | 32.9% | 36.6% | 27.9% | 26.7% | 14.1% | -15.7% | -47.3% |
| Leverage & debt balances | |||||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | N/A | N/A |
| Equity-to-Assets | 69.8% | 75.0% | 82.2% | 88.0% | 78.3% | 74.3% | 49.7% |
| Net Debt | -9 | -25 | -8 | -41 | -10 | -7 | -7 |
| Cash & Equivalents | 9 | 25 | 8 | 41 | 10 | 7 | 7 |
| Total Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Liquidity & working capital | |||||||
| Current Ratio | 2.97x | 3.58x | 4.59x | 6.93x | 3.88x | 2.79x | 1.36x |
| Quick Ratio | 2.97x | 0.74x | 0.73x | 6.93x | 3.88x | 2.79x | 1.36x |
| Cash Ratio | 0.05x | 0.17x | 0.06x | 0.45x | 0.06x | 0.04x | 0.02x |
| Total Current Assets | 505 | 542 | 580 | 625 | 689 | 523 | 416 |
| Total Current Liabilities | 170 | 151 | 126 | 90 | 178 | 187 | 305 |
| Inventory | N/A | 431 | 487 | N/A | N/A | N/A | N/A |
| Trade Receivables | 79 | 84 | 78 | 74 | 62 | 54 | 3 |
| Trade Payables | 170 | 151 | 126 | 90 | 178 | 187 | 305 |
| Net Working Capital | 335 | 391 | 454 | 535 | 512 | 335 | 110 |
| Net Working Capital % of Revenue | 13.3% | 13.4% | 14.9% | 17.0% | 17.9% | 15.4% | 4.8% |
| Trade Working Capital | -91 | 364 | 439 | -17 | -116 | -133 | -302 |
| Trade Working Capital % of Revenue | -3.6% | 12.5% | 14.4% | -0.5% | -4.0% | -6.1% | -13.0% |
| Change in Trade Working Capital | N/A | 455 | 76 | -456 | -99 | -18 | -168 |
| Turnover & efficiency | |||||||
| Inventory Turnover | N/A | 5.84x | 5.34x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | 62.5 | 68.3 | N/A | N/A | N/A | N/A |
| Receivables Turnover | 31.89x | 34.70x | 38.90x | 42.76x | 46.32x | 40.44x | 689.46x |
| Days Sales Outstanding (DSO) | 11.4 | 10.5 | 9.4 | 8.5 | 7.9 | 9.0 | 0.5 |
| Payables Turnover | 12.83x | 16.63x | 20.63x | 29.84x | 13.85x | 10.36x | 6.80x |
| Days Payable Outstanding (DPO) | 28.4 | 21.9 | 17.7 | 12.2 | 26.4 | 35.2 | 53.7 |
| Cash Conversion Cycle | -17.0 days | 51.1 days | 60.0 days | -3.7 days | -18.5 days | -26.2 days | -53.1 days |
| Asset Turnover | 4.47x | 4.81x | 4.30x | 4.17x | 3.50x | 2.99x | 3.81x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →